Literature DB >> 11773268

Prostate cancer in bone: importance of context for inhibition of matrix metalloproteinases.

Mina J Bissell, Johanne Le Beyec, Robin L Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11773268      PMCID： PMC3027556          DOI： 10.1093/jnci/94.1.4

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  21 in total

1.  Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

Authors:  L Bubendorf; A Schöpfer; U Wagner; G Sauter; H Moch; N Willi; T C Gasser; M J Mihatsch
Journal:  Hum Pathol       Date:  2000-05       Impact factor: 3.466

Review 2.  Why do cancer cells metastasize into particular organs?

Authors:  D Rusciano; M M Burger
Journal:  Bioessays       Date:  1992-03       Impact factor: 4.345

Review 3.  Fibronectin and its integrin receptors in cancer.

Authors:  E Ruoslahti
Journal:  Adv Cancer Res       Date:  1999       Impact factor: 6.242

4.  Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.

Authors:  J A Nemeth; J F Harb; U Barroso; Z He; D J Grignon; M L Cher
Journal:  Cancer Res       Date:  1999-04-15       Impact factor: 12.701

Review 5.  An odyssey from breast to bone: multi-step control of mammary metastases and osteolysis by matrix metalloproteinases.

Authors:  A Lochter; M J Bissell
Journal:  APMIS       Date:  1999-01       Impact factor: 3.205

6.  Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

Authors:  T Yoneda; A Sasaki; C Dunstan; P J Williams; F Bauss; Y A De Clerck; G R Mundy
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

7.  Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer.

Authors:  M Michael; B Babic; R Khokha; M Tsao; J Ho; M Pintilie; K Leco; D Chamberlain; F A Shepherd
Journal:  J Clin Oncol       Date:  1999-06       Impact factor: 44.544

Review 8.  Mechanisms of bone metastasis.

Authors:  G R Mundy
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

9.  Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.

Authors:  T C Thompson; S H Park; T L Timme; C Ren; J A Eastham; L A Donehower; A Bradley; D Kadmon; G Yang
Journal:  Oncogene       Date:  1995-03-02       Impact factor: 9.867

10.  Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells.

Authors:  A Lochter; S Galosy; J Muschler; N Freedman; Z Werb; M J Bissell
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539
View more
  5 in total

Review 1.  Future nanomedicine for the diagnosis and treatment of osteoarthritis.

Authors:  Lauren R Eichaker; Hongsik Cho; Craig L Duvall; Thomas A Werfel; Karen A Hasty
Journal:  Nanomedicine (Lond)       Date:  2014-07       Impact factor: 5.307

2.  Increased levels of urokinase plasminogen activator receptor in prostate cancer cells derived from repeated metastasis.

Authors:  Katie Forbes; Karin Gillette; Laura A Kelley; Inder Sehgal
Journal:  World J Urol       Date:  2004-03-30       Impact factor: 4.226

3.  Assessment of the potential of pathological stains in human prostate cancer.

Authors:  Anchit Khanna; Rani Patil; Abhay Deshmukh
Journal:  J Clin Diagn Res       Date:  2014-01-12

4.  Humanization of the Prostate Microenvironment Reduces Homing of PC3 Prostate Cancer Cells to Human Tissue-Engineered Bone.

Authors:  Jacqui A McGovern; Abbas Shafiee; Ferdinand Wagner; Christoph A Lahr; Marietta Landgraf; Christoph Meinert; Elizabeth D Williams; Pamela J Russell; Judith A Clements; Daniela Loessner; Boris M Holzapfel; Gail P Risbridger; Dietmar W Hutmacher
Journal:  Cancers (Basel)       Date:  2018-11-13       Impact factor: 6.639

5.  Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines.

Authors:  Anderson Junger Teodoro; Felipe Leite Oliveira; Nathalia Balthazar Martins; Guilherme de Azevedo Maia; Renata Brum Martucci; Radovan Borojevic
Journal:  Cancer Cell Int       Date:  2012-08-06       Impact factor: 5.722
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.